92 related articles for article (PubMed ID: 20182588)
1. Notch signaling pathway in cancer: from mechanistic insights to targeted therapies.
Shi Q; Xue C; Zeng Y; Yuan X; Chu Q; Jiang S; Wang J; Zhang Y; Zhu D; Li L
Signal Transduct Target Ther; 2024 May; 9(1):128. PubMed ID: 38797752
[TBL] [Abstract][Full Text] [Related]
2. DLL3 (delta-like protein 3) expression correlates with stromal desmoplasia and lymph node metastases in medullary thyroid carcinomas.
Ingenwerth M; Brandenburg T; Führer-Sakel D; Goetz M; Weber F; Dralle H; Schildhaus HU; Schmid KW; Theurer S
Endocr Connect; 2021 Mar; 10(3):283-289. PubMed ID: 33617464
[TBL] [Abstract][Full Text] [Related]
3. Notch Signaling in Thyroid Cancer.
Guenter R; Patel Z; Chen H
Adv Exp Med Biol; 2021; 1287():155-168. PubMed ID: 33034031
[TBL] [Abstract][Full Text] [Related]
4. Notch3 as a novel therapeutic target in metastatic medullary thyroid cancer.
Lou I; Odorico S; Yu XM; Harrison A; Jaskula-Sztul R; Chen H
Surgery; 2018 Jan; 163(1):104-111. PubMed ID: 29128180
[TBL] [Abstract][Full Text] [Related]
5. Targeted Therapy for Medullary Thyroid Cancer: A Review.
Priya SR; Dravid CS; Digumarti R; Dandekar M
Front Oncol; 2017; 7():238. PubMed ID: 29057215
[TBL] [Abstract][Full Text] [Related]
6. MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.
Spitschak A; Meier C; Kowtharapu B; Engelmann D; Pützer BM
Mol Cancer; 2017 Jan; 16(1):24. PubMed ID: 28122586
[TBL] [Abstract][Full Text] [Related]
7. Aberrant Activation of Notch Signaling Inhibits PROX1 Activity to Enhance the Malignant Behavior of Thyroid Cancer Cells.
Choi D; Ramu S; Park E; Jung E; Yang S; Jung W; Choi I; Lee S; Kim KE; Seong YJ; Hong M; Daghlian G; Kim D; Shin E; Seo JI; Khatchadourian V; Zou M; Li W; De Filippo R; Kokorowski P; Chang A; Kim S; Bertoni A; Furlanetto TW; Shin S; Li M; Chen Y; Wong A; Koh C; Geliebter J; Hong YK
Cancer Res; 2016 Feb; 76(3):582-93. PubMed ID: 26609053
[TBL] [Abstract][Full Text] [Related]
8. Induction of apoptosis and autophagy in metastatic thyroid cancer cells by valproic acid (VPA).
Xu Y; Xu D; Zhu SJ; Ye B; Dong JD; Zhang YL; Zhang Y
Int J Clin Exp Pathol; 2015; 8(7):8291-7. PubMed ID: 26339399
[TBL] [Abstract][Full Text] [Related]
9. Identification of novel thyroid cancer-related genes and chemicals using shortest path algorithm.
Jiang Y; Zhang P; Li LP; He YC; Gao RJ; Gao YF
Biomed Res Int; 2015; 2015():964795. PubMed ID: 25874234
[TBL] [Abstract][Full Text] [Related]
10. Tumor-suppressor role of Notch3 in medullary thyroid carcinoma revealed by genetic and pharmacological induction.
Jaskula-Sztul R; Eide J; Tesfazghi S; Dammalapati A; Harrison AD; Yu XM; Scheinebeck C; Winston-McPherson G; Kupcho KR; Robers MB; Hundal AK; Tang W; Chen H
Mol Cancer Ther; 2015 Feb; 14(2):499-512. PubMed ID: 25512616
[TBL] [Abstract][Full Text] [Related]
11. From fly wings to targeted cancer therapies: a centennial for notch signaling.
Ntziachristos P; Lim JS; Sage J; Aifantis I
Cancer Cell; 2014 Mar; 25(3):318-34. PubMed ID: 24651013
[TBL] [Abstract][Full Text] [Related]
12. Chrysin activates Notch1 signaling and suppresses tumor growth of anaplastic thyroid carcinoma in vitro and in vivo.
Yu XM; Phan T; Patel PN; Jaskula-Sztul R; Chen H
Cancer; 2013 Feb; 119(4):774-81. PubMed ID: 22991264
[TBL] [Abstract][Full Text] [Related]
13. Signaling mechanisms in neuroendocrine tumors as targets for therapy.
Zarebczan B; Chen H
Endocrinol Metab Clin North Am; 2010 Dec; 39(4):801-10. PubMed ID: 21095546
[TBL] [Abstract][Full Text] [Related]
14. Notch in the development of thyroid C-cells and the treatment of medullary thyroid cancer.
Cook M; Yu XM; Chen H
Am J Transl Res; 2010 Feb; 2(1):119-25. PubMed ID: 20182588
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of the NOTCH1 intracellular domain inhibits cell proliferation and alters the neuroendocrine phenotype of medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
J Biol Chem; 2006 Dec; 281(52):39819-30. PubMed ID: 17090547
[TBL] [Abstract][Full Text] [Related]
16. Xanthohumol inhibits the neuroendocrine transcription factor achaete-scute complex-like 1, suppresses proliferation, and induces phosphorylated ERK1/2 in medullary thyroid cancer.
Cook MR; Luo J; Ndiaye M; Chen H; Kunnimalaiyaan M
Am J Surg; 2010 Mar; 199(3):315-8; discussion 318. PubMed ID: 20226902
[TBL] [Abstract][Full Text] [Related]
17. Small cell lung cancer, an epithelial to mesenchymal transition (EMT)-like cancer: significance of inactive Notch signaling and expression of achaete-scute complex homologue 1.
Ito T; Kudoh S; Ichimura T; Fujino K; Hassan WA; Udaka N
Hum Cell; 2017 Jan; 30(1):1-10. PubMed ID: 27785690
[TBL] [Abstract][Full Text] [Related]
18. Suberoyl bis-hydroxamic acid activates Notch-1 signaling and induces apoptosis in medullary thyroid carcinoma cells.
Ning L; Greenblatt DY; Kunnimalaiyaan M; Chen H
Oncologist; 2008 Feb; 13(2):98-104. PubMed ID: 18305053
[TBL] [Abstract][Full Text] [Related]
19. Medullary thyroid cancer: the functions of raf-1 and human achaete-scute homologue-1.
Chen H; Kunnimalaiyaan M; Van Gompel JJ
Thyroid; 2005 Jun; 15(6):511-21. PubMed ID: 16029117
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
